QCM
IRON icon

Quantinno Capital Management’s Disc Medicine IRON Stock Holding History

Quantinno Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534K Buy
+7,297
New +$501K ﹤0.01% 2949

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quantinno Capital Management's IRON Position: Q2 2026 in Review

Quantinno Capital Management opened a new position in Disc Medicine (IRON) in Q2 2026: 7,297 shares worth $534K. The stake represents ﹤0.01% of the portfolio and ranks #2949 among its holdings.

215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Quantinno Capital Management held 7,297 shares of Disc Medicine worth $534K as of Q2 2026.
  • Disc Medicine was a new Quantinno Capital Management position in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2949 holding.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.